CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
Clinical trials for CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME trials appear
Sign up with your email to follow new studies for CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug shows promise for kids with aggressive brain cancers
Disease control OngoingThis study tests a drug called pembrolizumab in children whose brain tumors have come back or not responded to treatment. The drug helps the body's immune system fight cancer cells. The goal is to find the safest dose and see if it can shrink tumors in children with several types…
Matched conditions: CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:58 UTC
-
Childhood cancer immunotherapy trial pulled before starting
Disease control TerminatedThis study was designed to test two immunotherapy drugs, nivolumab and ipilimumab, in children and young adults with cancers that returned or didn't respond to treatment and have many genetic mutations. The goal was to see if the combination could shrink tumors or help patients l…
Matched conditions: CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC